Kumamoto, Yoshihiko <br/><br/>
"FAR" chemoradiotherapy improves laryngeal preservation rates in patients with T2N0 glottic carcinoma.  [electronic resource] 

 -  Head & neck  Jul 2002 
 - 637-42 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1043-3074 
<br/><br/><label>Standard No.: </label>10.1002/hed.10114  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antimetabolites, Antineoplastic--therapeutic use<br/>Female<br/>Fluorouracil--therapeutic use<br/>Glottis<br/>Humans<br/>Laryngeal Neoplasms--drug therapy<br/>Laryngectomy<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local<br/>Vitamin A--therapeutic use